Collins F M, Morrison N E
Infect Immun. 1976 Feb;13(2):564-8. doi: 10.1128/iai.13.2.564-568.1976.
Calf thymosin was injected subcutaneously in daily doses of 0.1 to 3 mg for 12 to 15 days into adult thymectomized, irradiated, bone marrow-reconstituted (THXB) mice. Thymosin partially restored the ability of the T-cell-depleted host to develop delayed-type hypersensitivity to sheep erythrocytes. The degree of restoration varied from 50 to 75% of control values. Thymosin treatment of normal mice potentiated the footpad responsiveness to sheep erythrocytes by as much as 50% over that of untreated controls. The optimum dosage of thymosin seemed to be in the 200- to 500-mug range, and multiple injections were essential for a significant response. Tweleve daily injections of 100 to 500 mug of thymosin restored T-cell reactivity to the THXB mouse, but the responsiveness decayed relatively rapidly once the treatment was stopped. The restoration of immune responsiveness to sheep erythrocytes in T-cell-depleted mice provides a convenient means of demonstrating activity in thymosin preparations in vivo.
将小牛胸腺素以每天0.1至3毫克的剂量皮下注射到成年去胸腺、经辐射、骨髓重建(THXB)的小鼠体内,持续12至15天。胸腺素部分恢复了T细胞耗竭宿主对绵羊红细胞产生迟发型超敏反应的能力。恢复程度为对照值的50%至75%。胸腺素对正常小鼠的治疗使足垫对绵羊红细胞的反应性比未治疗的对照增强了多达50%。胸腺素的最佳剂量似乎在200至500微克范围内,多次注射对于显著反应至关重要。每天注射12次100至500微克的胸腺素可恢复THXB小鼠的T细胞反应性,但一旦停止治疗,反应性相对较快地下降。T细胞耗竭小鼠对绵羊红细胞免疫反应性的恢复为在体内证明胸腺素制剂的活性提供了一种便捷方法。